Clinical trial

Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis

NCT00356473

Study summary

ClinicalTrials.gov

Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Atorvastatin Normalized identity: atorvastatin View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-03-01

PhasePHASE4

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

AtorvastatinDRUG · verified · RxNorm: atorvastatin

Sponsors & collaborators

University of California, Los Angeleslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00356473 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.